Jenburkt Pharmaceuticals Ltd — Updates, 03-06-2025: Company Update

Jenburkt Pharmaceuticals Limited has announced the proposed transfer of equity shares and corresponding unclaimed dividends to the Investor Education and Protection Fund (IEPF) Authority. Shares with dividends unclaimed for seven consecutive years will be moved to the IEPF account if claims are not received by shareholders by the specified deadline. Shareholders can reclaim their shares and dividends later by applying through the IEPF process. Details of affected shareholders and shares liable for transfer are available on the company’s website. This action impacts shareholders with unclaimed dividends, ensuring compliance and fund consolidation.